BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36341742)

  • 1. Recurrence and Survival Rates of Patients Who Undergo Minimally Invasive Surgery for Endometrial Carcinoma with Different Prognostic Risk Groups.
    Liu B; Lin J; Liu W; Chen W; Lin W; Chen W
    J Invest Surg; 2023 Dec; 36(1):1-10. PubMed ID: 36341742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival rates of patients who undergo minimally invasive surgery for endometrial cancer with cervical involvement.
    Kim SI; Park DC; Lee SJ; Song MJ; Kim CJ; Lee HN; Yoon JH
    Int J Med Sci; 2021; 18(10):2204-2208. PubMed ID: 33859528
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
    Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
    Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive surgery for patients with advanced stage endometrial cancer.
    Kim SI; Park DC; Lee SJ; Yoo JG; Song MJ; Kim CJ; Lee HN; Yoon JH
    Int J Med Sci; 2021; 18(5):1153-1158. PubMed ID: 33526975
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.
    Koskas M; Jozwiak M; Fournier M; Vergote I; Trum H; Lok C; Amant F
    Eur J Cancer; 2016 Sep; 65():185-91. PubMed ID: 27505629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?
    Monterossi G; Ghezzi F; Vizza E; Zannoni GF; Uccella S; Corrado G; Restaino S; Quagliozzi L; Casarin J; Dinoi G; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2017; 24(3):438-445. PubMed ID: 28065812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
    Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
    Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
    Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
    Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
    Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
    Dai Y; Wang Z; Wang J
    Gynecol Oncol; 2020 Jul; 158(1):92-98. PubMed ID: 32376044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.
    Dai D; Huang H; Feng Y; Wan T; Liu Z; Tong C; Liu J
    Cancer Med; 2020 Dec; 9(24):9236-9245. PubMed ID: 33236825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
    Kim Y; Kim SI; Kim H; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Lee C; Suh DH
    Gynecol Oncol; 2022 Oct; 167(1):28-36. PubMed ID: 35970602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan.
    Chang CS; Lai YL; Choi CH; Kim TJ; Lee JW; Kim BG; Cheng WF; Chen YL; Lee YY
    Ann Surg Oncol; 2023 Oct; 30(11):6855-6864. PubMed ID: 37386310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP).
    Feigenberg T; Cormier B; Gotlieb WH; Jegatheeswaran K; Helpman L; Kim SR; Lau S; May T; Saab D; Plante M; Renaud MC; Samouelian V; Shamiya S; Vicus D; Wright K; Kwon JS
    Gynecol Oncol; 2021 Sep; 162(3):606-612. PubMed ID: 34183164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective study.
    Perri T; Levin G; Helpman L; Eitan R; Vaknin Z; Lavie O; Ben Arie A; Amit A; Levy T; Namazov A; Ben Shachar I; Atlas I; Bruchim I; Kogan L; Gemer O
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():43-47. PubMed ID: 34800816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
    Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
    J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer.
    Segarra-Vidal B; Dinoi G; Zorrilla-Vaca A; Mariani A; Student V; Garcia NA; Llueca Abella A; Ramirez PT
    Obstet Gynecol; 2021 Dec; 138(6):828-837. PubMed ID: 34735382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUrgical Access and Pattern of Recurrence of Endometrial Cancer: The SUPeR Study, a Multicenter Retrospective Observational Study.
    Puppo A; Migliaretti G; Landoni F; Uccella S; Camanni M; Ceccaroni M; Delpiano EM; Mantovani G; Roviglione G; Bianchi T; Grassi T; Maggi V; Garzon S; Galli L; Calandra V; Olearo E
    J Minim Invasive Gynecol; 2024 Apr; 31(4):321-329. PubMed ID: 38301845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.